Search results for "Drug-Induced"

showing 3 items of 43 documents

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey

2014

Background and Aims Inflammatory bowel diseases (IBD) are frequently associated with altered liver function tests (LFTs). The causal relationship between abnormal LFTs and IBD is unclear. The aim of our study was to evaluate the prevalence and etiology of LFTs abnormalities and their association with clinical variables in a cohort of IBD patients followed up in a single center. Materials and Methods A retrospective review was undertaken of all consecutive IBD in- and outpatients routinely followed up at a single referral center. Clinical and demographic parameters were recorded. Subjects were excluded if they had a previous diagnosis of chronic liver disease. LFT abnormality was defined as …

medicine.medical_specialtyPathologySettore MED/09 - Medicina Internadrug-induced hepatotoxicityChronic liver diseaseInflammatory bowel diseaseGastroenterologyCholestasisinflammatory bowel diseaseInternal medicinemedicinelcsh:RC799-869Original Researchfatty liverLiver injurymedicine.diagnostic_testbusiness.industryFatty liverGastroenterologymedicine.diseaseCohortEtiologylcsh:Diseases of the digestive system. Gastroenterologyliver function testsbusinessLiver function testsClinical Medicine Insights: Gastroenterology
researchProduct

Optimizing diagnostic approach to drug-induced liver injury

2018

Drug-induced liver injury (DILI) is often a trial even to expert clinicians, because sometimes diagnosis is not easy to be made. Guidelines of the American College of Gastroenterology (ACG) yielded in 2014, help to better understand the problem. The diagnosis of DILI is made through a detailed evaluation of clinical, serological, radiological and histological aspects. Biochemical data include liver function tests that allow to assess the pattern of damage, such as hepatocellular, cholestatic and mixed liver injury; serological data include testing for major and possibly minor hepatotropic viruses, non-organ specific autoantibodies. Clinical scenario might include jaundice, nausea, vomiting …

medicine.medical_specialtySettore MED/09 - Medicina InternaDrug-induced liver injurydiagnosisclinical approach.lcsh:MedicineClinical approach03 medical and health sciencesDrug withdrawalLiver disease0302 clinical medicinemedicineEosinophiliaLiver injurymedicine.diagnostic_testbusiness.industryMedicine (all)lcsh:RGeneral MedicineJaundicemedicine.disease030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologyRadiologymedicine.symptomTransient elastographybusinessLiver function testsDiagnosiItalian Journal of Medicine
researchProduct

Synchronous Antithyroid Drug-Induced Agranulocytosis and Fournier Gangrene

2018

ABSTRACT: Objective: Antithyroid drugs (ATDs) such as thioimidazoles (e.g., methimazole, also called thiamazole, and carbimazole) and propylthiouracil are commonly used for the treatment of hyperthyroidism. A life-threatening reaction is agranulocytosis with an incidence of 0.1 to 0.5%. There are very few cases in the literature showing that the intake of ATDs finally led to sepsis with accompanying tissue necrosis.Methods: We present an unusual case of severe symptomatic agranulocytosis with sudden development of Fournier gangrene in a patient who was treated with ATDs for hyperthyroidism due to Graves disease.Results: A 69-year-old female was referred to our hospital with fever and a sore…

medicine.medical_specialtyendocrine system diseasesGraves' disease030209 endocrinology & metabolismGastroenterologyDiseases of the endocrine glands. Clinical endocrinologySepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineSore throat030212 general & internal medicinebusiness.industryIncidence (epidemiology)Fournier gangreneGeneral MedicineRC648-665medicine.diseaseDrug-induced agranulocytosisSurgeryCarbimazolePropylthiouracilmedicine.symptombusinessmedicine.drugAACE Clinical Case Reports
researchProduct